tradingkey.logo

BRIEF-Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives

ReutersDec 26, 2024 9:58 PM

- Viracta Therapeutics Inc VIRX.O:

  • VIRACTA THERAPEUTICS ANNOUNCES CLOSURE OF NAVAL-1 CLINICAL TRIAL AND EXPLORATION OF STRATEGIC ALTERNATIVES

  • VIRACTA THERAPEUTICS INC - TO CLOSE PHASE 2 CLINICAL TRIAL OF NANA-VAL

  • VIRACTA THERAPEUTICS INC - CLOSURE OF TRIAL NOT DUE TO NEW SAFETY FINDING

  • VIRACTA THERAPEUTICS INC - POTENTIAL ALTERNATIVES INCLUDE MERGER, LICENSING AGREEMENT, SALE

Source text: ID:nGNXbcqMCQ

Further company coverage: VIRX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI